Novo Nordisk
Displaying 1 to 2 of 2 entries
Novo Nordisk: History, Innovation and Health Care
Date of Founding and Pedigree
Novo Nordisk, a world leader in pharmaceuticals for the treatment of diabetes, was founded on 16 January 1923 in Copenhagen, Denmark. The company began its journey by producing insulin, which was a medical breakthrough that saved millions of lives of people facing diabetes.
Mission and Values
Since its inception, the company has been committed to improving the quality of life of patients. Their primary mission is to develop innovative medicines and therapies that address diabetes and other chronic diseases. The company is committed to values including responsibility, trust, and respect for people.
Country of Manufacture and Global Network
Novo Nordisk is now an international company with a presence in more than 170 countries. It operates state-of-the-art manufacturing facilities in various parts of the world, including Denmark, China, Brazil, and the United States. This global reach ensures a stable and efficient supply of medicines to patients around the world.
Innovation and Scientific Excellence
One of the key traits of the company is its constant endeavour to innovate. The company invests heavily in research and development to create products that meet the growing needs of patients. Their scientific advances cover not only the field of diabetes, but also other areas of medicine such as haematology, endocrinology and blood clotting disorders.
Product Line
The manufacturer offers a diverse range of products for the treatment of diabetes, including insulins of various types, oral preparations and injectable therapies. The company is also actively working on the development of new formulations and drug delivery methods to make treatment more effective and convenient for patients.
Commitment to Sustainability
The Company attaches great importance to sustainable development and environmental responsibility. The company strives to minimise its ecological footprint and participates in many programmes aimed at improving society and the environment.
Today, the brand is not only one of the leading manufacturers of diabetes medicines, but also a flagship of innovation and research in the field of medicine. Founded on more than a century of experience, the company continues to focus on the needs of patients, giving hope for a healthier future.